You are here: Home » Companies » Results
India home healthcare industry to hit $11-13 billion by 2025: Report
HDFC net profit dips to Rs 2,870 cr in Q2, net interest income rises 21%
Business Standard

Zydus Cadila Q2 net up four-fold on surge in US sales, strong show at home

Firm prunes net debt by 40% since March 2020; consolidated income up 13%

Topics
Zydus Cadila | Q2 results | pharmaceutical firms

Vinay Umarji  |  Ahmedabad 



v
Zydus Cadila is a front-runner in Covid-19 vaccine development

On the back of an 18 per cent growth in its US sales and 11 per cent growth in its India business, Cadila Healthcare Ltd. (Zydus Cadila) registered a 341.60 per cent jump in its consolidated profit after tax (PAT) for the quarter ended September 30, 2020. The company grew its net profit for Q2 of FY21 to Rs 473.4 crore from Rs 107.2 crore in corresponding Q2 of previous fiscal year 2019-20.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Mon, November 02 2020. 17:56 IST

RECOMMENDED FOR YOU

.